This brand name is authorized in Hong Kong, Japan, Singapore
The drug NESP contains one active pharmaceutical ingredient (API):
1
Darbepoetin alfa
UNII 15UQ94PT4P - DARBEPOETIN ALFA
|
Darbepoetin alfa stimulates erythropoiesis by the same mechanism as the endogenous hormone. Darbepoetin alfa has five N-linked carbohydrate chains whereas the endogenous hormone and recombinant human erythropoietins (r-HuEPO) have three. The additional sugar residues are molecularly indistinct from those on the endogenous hormone. Due to its increased carbohydrate content darbepoetin alfa has a longer terminal half-life than r-HuEPO and consequently a greater in vivo activity. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
B03XA02 | Darbepoetin alfa | B Blood and blood forming organs → B03 Antianemic preparations → B03X Other antianemic preparations → B03XA Other antianemic preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: HK | Department of Health Drug Office | Identifier(s): 63111, 63112, 63115, 63117 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3999425S5028, 3999425S6024, 3999425S7020, 3999425S8027, 3999425S9023, 3999425U1023, 3999425U2020, 3999425U3026, 3999425U4022 |
Country: SG | Health Sciences Authority | Identifier(s): 14739P, 14740P, 14741P, 14742P, 14743P, 14744P, 14745P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.